Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Nascent Biotech Inc.

Nascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patent
From Nascent Biotech Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers NBIO
Nascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancer
From Nascent Biotech Inc.
Via AccessWire
Tickers NBIO
Nascent Biotech's CEO Sean Carrick Featured in In-Depth Interview with Proactive Investors
From Nascent Biotech Inc.
Via AccessWire
Tickers NBIO
Nascent Biotech and BioTools Partner in the Fight Against Cancer Using ROA to Define the Higher Order Structure of PTB, a Unique Monoclonal Antibody
From Nascent Biotech Inc.
Via AccessWire
Tickers NBIO
The Laurel Amtower Cancer Institute and Neuro-Oncology Center at Sharp HealthCare to Join Innovative Antibody Brain Cancer Drug Trial
From Nascent Biotech Inc.
Via AccessWire
Tickers NBIO
Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical
From Nascent Biotech Inc.
Via AccessWire
Tickers NBIO
Nascent Successfully Completes 2nd Cohort Dosing in Key Phase 1 Metastatic Brain Cancer Trial
From Nascent Biotech Inc.
Via AccessWire
Tickers NBIO
Nascent Biotech and Manhattan BioSolutions Announce Promising Prelim/Preclinical Results in BCG-Based COVID-19 Vaccine Research Collaboration
From Nascent Biotech Inc.
Via AccessWire
Exposures COVID-19
Tickers NBIO
Marble Arch Research Publishes Analyst Research Report on Nascent Biotech
From Nascent Biotech Inc.
Via AccessWire
Exposures COVID-19
Tickers NBIO
Nascent Biotech Commencing Enrollment of Second Cohort in Phase 1 Human Trial for Primary and Metastatic Brain Cancer
From Nascent Biotech Inc.
Via AccessWire
Exposures COVID-19
Tickers NBIO
Nascent Biotech and BioRay Pharmaceutical Announce $5,000,000 Exclusive License Agreement for Development and Commercialization of Nascent's Pritumumab
From Nascent Biotech Inc.
Via AccessWire
Exposures COVID-19 Product Safety
Tickers NBIO
Nascent Biotech Continues Anti-Dilution Campaign with Preemptive Settlement of Outstanding Convertible Note
From Nascent Biotech Inc.
Via AccessWire
Exposures COVID-19
Tickers NBIO
Nascent Biotech Announces Pre-emptive Elimination of Significant Tranche of Convertible Debt
From Nascent Biotech Inc.
Via AccessWire
Exposures COVID-19
Tickers NBIO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.